Great science may start innovation, but scaling it takes collaboration, data and the right digital foundations.

BIO International Convention 2026 brought together leading voices from across the global biotech ecosystem, and BioSpectrum Asia has captured many of those conversations in its The Voices series.

Among them is our CEO, Alexander Seyf, on why interoperability, AI-enabled manufacturing and digital infrastructure will define the next chapter of advanced therapies.

For a sense of what the industry is actually talking about right now, start here.

🔗 The Voices: see linked here.

🔗 Alexander Seyf’s take: see linked here.